Home> Meet us> HARMONY Alliance will present results at the ASH annual meeting 2021

HARMONY Alliance will present results at the ASH annual meeting 2021

Hybrid | Atlanta, USA

December 11, 2021 08:00 - December 14, 2021 - 20:00

The HARMONY Alliance will present new results of Big Data Research Projects at the 63nd Annual Meeting of the American Society of Hematology (ASH), taking place as a hybrid meeting on December 11–14, 2021. 

In addition, representatives of ASH and HARMONY will participate in an inspiring dedicated session about the role of Real-World data collection in Hematologic Malignancies.

New HARMONY results in AML and CLL

At ASH 2021, HARMONY researchers will present new results related to Acute Myeloid Leukemia (AML) and to Chronic Lymphocytic Leukemia (CLL). Using data from thousands of patients with CLL, they have produced new insights that may be used to identify patients with an unfavorable prognosis. This may result in better-informed treatment choices in the future.



Dedicated ASH-HARMONY session

This joint session about the role of Real-World data collection in Hematologic Malignancies will take place on December 12, 2021 4:30-6:00PM EST (Georgia World Congress Center, B312-B314) and will address:

Session speakers

ASH 2021: Participants will be able to join the meeting either in person at the Georgia World Congress Center in Atlanta, Georgia or virtually. The ASH Annual Meetings provide a unique opportunity for hematology professionals to exchange knowledge and expertise on a wide range of topics, hear the latest scientific discoveries in the field of hematology, and explore strategies to improve clinical practice and patient outcomes. Click here to visit the official ASH congress website >

ASH2020: Read about the HARMONY Alliance participation in the previous edition of the ASH Annual Meeting >


#BigDataforbloodcancer | Big Data accelerate better and faster treatment for Patients with Hematologic Malignancies

The HARMONY Alliance is a European Public–Private Partnership for Big Data in Hematology that is capturing and mining Big Data on various Hematologic Malignancies. The HARMONY Alliance, funded by Innovative Medicines Initiative, unites more than 100 organizations such as European medical associations, hospitals, research institutes, patient organizations, pharmaceutical and IT companies. HARMONY uses Big Data analytics to accelerate the development of more effective treatments for blood cancer patients. The aim is to accelerate the development of more effective treatments. Data are stored in HARMONY’s Big Data Platform, which has already identified over 80,000 anonymized patient records, making it one of the largest databases of its kind. Leading research teams are currently using this wealth of information to answer critical questions about hematologic malignancies that cannot be addressed with other methods. 

Receive the latest news. Click here to subscribe!